UBRETID Tablet Ref.[2752] Active ingredients: Distigmine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2009  Publisher: Sanofi-aventis, One Onslow Street, Guildford, Surrey, GU1 4YS, UK

Product name and form

UbretidTM.

Pharmaceutical Form

Tablets.

Qualitative and quantitative composition

Active ingredient Distigmine bromide 5mg.

Active Ingredient Description
Distigmine
List of Excipients

Lactose
Maize starch
Purified talc
Magnesium stearate

Pack sizes and marketing

Blisters of 20μm aluminium foil and 250μm UPVC/PVdC opaque white film containing 30 tablets.

Marketing authorization holder

Sanofi-aventis, One Onslow Street, Guildford, Surrey, GU1 4YS, UK

Marketing authorization dates and numbers

PL 04425/0617

7 February 2009

Drugs

Drug Countries
UBRETID Austria, Estonia, Hong Kong, Japan, Netherlands, Poland, Singapore
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈